Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm

This study has been completed.
Sponsor:
Collaborator:
Cetero Research, San Antonio
Information provided by:
Teva Pharmaceutical Industries
ClinicalTrials.gov Identifier:
NCT00964730
First received: August 21, 2009
Last updated: April 6, 2010
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)